Huberman LabDiet & Nutrition for Mental Health | Dr. Chris Palmer
CHAPTERS
- 0:00 – 13:00
Introduction: Metabolism Meets Mental Health
Andrew Huberman introduces Dr. Chris Palmer as a Harvard psychiatrist leading a paradigm shift: linking metabolic disorders and mitochondrial dysfunction to psychiatric illnesses. He frames the episode around how nutrition—especially ketogenic diets and fasting—can causally influence mental health, not just weight, across conditions like depression, OCD, ADHD, anxiety, psychosis, and obesity.
- 13:00 – 34:00
Dr. Palmer’s Personal Journey: From OCD and Metabolic Syndrome to Low-Carb
Palmer recounts his childhood OCD, family trauma, homelessness, depression, suicidality, and years of unhelpful psychotherapies and medications. In residency at Harvard, he developed metabolic syndrome despite following mainstream low-fat advice, then reversed his metabolic and mental symptoms with an Atkins-style low-carb diet.
- 34:00 – 47:40
Early Clinical Experiments: Low-Carb as an Antidepressant
Seeing his own transformation and similar improvements in family, Palmer cautiously began offering low-carb and ketogenic diets to treatment-resistant depression patients. He found that clinical benefits often appeared only once patients achieved measurable ketosis, prompting more systematic use despite fears of being seen as fringe.
- 47:40 – 59:00
Designing and Titrating Ketogenic Diets in Practice
Palmer explains how he initially 'winged' dietary protocols and then evolved to more structured ketogenic prescriptions, including blood ketone monitoring. He differentiates between using diet as a lifestyle tweak versus a serious brain treatment, and discusses fasting, fat-fasts, and target ketone ranges for different conditions.
- 59:00 – 1:13:00
A Landmark Case: Schizoaffective Disorder Remits on Keto
Palmer describes a 33‑year‑old man with schizoaffective disorder, daily hallucinations, and persecutory delusions, unresponsive to 17 medications, who weighed 340 lbs. Seeking weight loss for self-esteem, the patient agreed to a ketogenic diet that unexpectedly transformed his psychiatric state, challenging everything Palmer knew about schizophrenia treatment.
- 1:13:00 – 1:22:20
Adherence, Monitoring, and Medication Safety
The discussion turns to practicalities: why ketogenic diets are difficult to maintain, how ketosis offers a unique objective biomarker of adherence, and why medication changes must be slow and supervised to avoid dangerous withdrawal or relapse. Palmer contrasts this with typical prescribing practices where adherence is often assumed rather than verified.
- 1:22:20 – 1:34:20
Epilepsy and the Origins of Medical Ketogenic Therapy
Palmer outlines the 100-year history of ketogenic diets as epilepsy treatments, beginning with observations that fasting reduces seizures. The ketogenic diet was invented to mimic the fasting state metabolically without starvation, and later revived when ~30% of epilepsy patients proved resistant to modern anticonvulsant drugs.
- 1:34:20 – 1:53:40
Mitochondria, Mitophagy, and Mitochondrial Biogenesis: The Core Mechanism
The conversation zooms in on mitochondria as central regulators of brain metabolism and mental health. Palmer explains how ketogenic states and fasting induce mitophagy (removing damaged mitochondria) and mitochondrial biogenesis (creating more, healthier mitochondria), and why that likely underlies keto’s broad neurological and psychiatric effects.
- 1:53:40 – 2:09:00
Glucose, Ketones, and Brain Fuel: Untangling the Paradox
Huberman raises a core paradox: neurons 'love' glucose, yet many patients seem to think, feel, and function better when glucose is lowered and ketones are elevated. Palmer argues that high glucose is often a symptom of underlying mitochondrial dysregulation and that ketones preferentially rescue metabolically impaired cells, enabling repair.
- 2:09:00 – 2:26:00
Alcohol Use Disorder, Ketosis, and Addiction Metabolism
Palmer discusses NIH research showing ketogenic diets can help treat alcoholism by correcting reward-circuit energy deficits. However, he cautions that ketosis may dramatically increase blood alcohol levels upon relapse, raising safety concerns. He also notes that THC directly impairs mitochondrial function via CB1 receptors.
- 2:26:00 – 2:49:00
Alzheimer’s Disease and Cognitive Decline: Early Keto Trials and Obstacles
The discussion shifts to Alzheimer’s disease, where brain glucose hypometabolism is well documented. Small randomized trials suggest ketogenic or lower-carb diets can improve daily functioning and quality of life, and ketone supplements can normalize regional brain metabolism. But large trials are hampered by adherence challenges, especially in cognitively impaired patients.
- 2:49:00 – 3:09:00
Designing 'Doses' of Diet: Protocols, Fasting, and Individualization
Palmer outlines how he customizes dietary 'doses' much like medication. He contrasts approaches for obese vs lean patients, explains when he layers in intermittent or prolonged fasting, and describes monitoring strategies and target ketone ranges. Huberman adds practical questions about timing carbs to support both alertness and sleep.
- 3:09:00 – 3:27:00
Sleep, Hypomania, and Managing Side Effects of Keto
They examine a key side effect: keto-induced hypomania characterized by reduced sleep need, elevated mood, and high productivity, which can become unhealthy and destabilizing. Palmer describes behavioral, nutritional, and pharmacologic tools to restore adequate sleep while preserving keto’s benefits, especially in bipolar-spectrum patients.
- 3:27:00 – 3:44:00
Hormones, Fertility, and Sex Differences on Keto
Palmer addresses how ketogenic diets interact with endocrine function and fertility. Data and clinical observations show mixed, sometimes opposite effects in men and women, particularly around female fertility and menstrual cycles, highlighting the need for more research and cautious, individualized use.
- 3:44:00 – 4:04:00
Obesity, GLP‑1 Drugs, and the Limits of Symptom-Only Approaches
In closing, Palmer situates obesity and GLP‑1 agonists (e.g., semaglutide) within his mitochondrial framework. He warns that while new drugs may assist with weight loss, they likely do not resolve the upstream mitochondrial dysfunction driving both obesity and many mental disorders, and could repeat past patterns of short-term wins and long-term disappointments.
- 4:04:00
Conclusion: A Mitochondrial Model for Mental Health
Huberman thanks Palmer for pioneering work that reframes mental illness as largely metabolic and mitochondrial. They reiterate that dietary interventions are not meant to replace medication wholesale but to expand the toolkit of evidence-based brain treatments. Palmer encourages rigorous trials and medically supervised implementation, especially for severe conditions.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome